Elisa Buzzatti

11PUBLICATIONS
72CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 28, 2026
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients.

Elisa Buzzatti, Cristina Mauro, Cristiano Tesei

|Jun 26, 2025
Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy.

Elisa Buzzatti, Giovangiacinto Paterno, Raffaele Palmieri

|Jun 10, 2025
Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens.

Claudia Matteucci, Vita Petrone, Alessandro Giovinazzo

|Feb 26, 2025
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response.

Valeria Mezzanotte, Giovangiacinto Paterno, Ilaria Cerroni

|Sep 28, 2023
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.

Nicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis

|Feb 25, 2023
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML.

Elisa Meddi, Arianna Savi, Federico Moretti

Pageof 2

Frequent Collaborators

7 joint publications

Adriano Venditti

7 joint publications

Maria Ilaria Del Principe

6 joint publications

Francesco Buccisano

5 joint publications

Raffaele Palmieri